Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer.
Chang
Gee-Chen
GC
Taichung Veterans General Hospital and Chung Shan Medical University, Taiwan.
Yang
Tsung-Ying
TY
Chen
Kun-Chieh
KC
Yin
Ming-Chang
MC
Wang
Ren-Ching
RC
Lin
Yung-Chiou
YC
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors; D005260:Female; D000077156:Gefitinib; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D010304:Paronychia / Q000139:chemically induced*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011799:Quinazolines; D004815:Epidermal Growth Factor; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib